The myelodysplastic syndromes in 1996: Complex stem cell disorders confounded by dual actions of cytokines
- 31 December 1996
- journal article
- editorial
- Published by Elsevier in Leukemia Research
- Vol. 20 (11-12) , 881-890
- https://doi.org/10.1016/s0145-2126(96)00027-6
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- FAB classification of myelodysplastic syndromes: merits and controversiesAnnals of Hematology, 1995
- Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1994
- Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancerEuropean Journal Of Cancer, 1993
- Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemiaAmerican Journal of Hematology, 1993
- Contribution ofin vivo proliferation/differentiation studies toward the development of a combined functional and morphologic system of classification of neoplastic diseasesCancer, 1992
- Therapy of Secondary Acute Nonlymphocytic Leukemia with CytarabineNew England Journal of Medicine, 1983
- Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemiasLeukemia Research, 1983
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Bone marrow biopsy instead of ‘marrow juice’ for cell kinetic analysis comparison of bone marrow biopsy and aspiration materialLeukemia Research, 1982
- Studies on Human PreleukaemiaScandinavian Journal of Haematology, 1977